ETNK1 (ethanolamine kinase 1)

2014-08-01  

Identity

HGNC
LOCATION
12p12.1
LOCUSID
ALIAS
EKI,EKI
FUSION GENES

Other Information

Locus ID:

NCBI: 55500
MIM: 609858
HGNC: 24649
Ensembl: ENSG00000139163

Variants:

dbSNP: 55500
ClinVar: 55500
TCGA: ENSG00000139163
COSMIC: ETNK1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000139163ENST00000266517Q9HBU6
ENSG00000139163ENST00000335148Q9HBU6
ENSG00000139163ENST00000335148Q86U68
ENSG00000139163ENST00000538218H0YH69
ENSG00000139163ENST00000545979H0YFP7

Expression (GTEx)

0
5
10
15
20
25
30
35
40

Pathways

PathwaySourceExternal ID
Glycerophospholipid metabolismKEGGko00564
Glycerophospholipid metabolismKEGGhsa00564
Metabolic pathwaysKEGGhsa01100
Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PEKEGGhsa_M00092
Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PEKEGGM00092
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Phospholipid metabolismREACTOMER-HSA-1483257
Glycerophospholipid biosynthesisREACTOMER-HSA-1483206
Synthesis of PEREACTOMER-HSA-1483213

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
365832292023ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia.0
365832292023ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia.0
332300962020ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine.20
332300962020ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine.20
312553312019miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.16
312553312019miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.16
253439572015Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.51
256152812015Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.23
253439572015Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.51
256152812015Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.23
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.78
206280862010Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.15
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.78
206280862010Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.15
199131212009Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.105

Citation

Dessen P

ETNK1 (ethanolamine kinase 1)

Atlas Genet Cytogenet Oncol Haematol. 2014-08-01

Online version: http://atlasgeneticsoncology.org/gene/54292/img/gene-fusions/favicon/favicon-16x16.png